NCT01192659View on ClinicalTrials.gov

Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

16,492

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Diabetes Mellitus, Type 2

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY